Pershing Square IPO Bill Ackmans Hedge Fund Plans Dual Stock Listing on NYSE Renegade Prepares for Belmont Stakes After Close Kentucky Derby Finish Senegals President Sacks Prime Minister and Dissolves Government Deepening Uncertainty Amid Debt Crisis The Office Lunch Evolution From Luxury to Workplace Burden Analyst Report Highlights Potential Growth Trajectory for Walmart Inc Amid Evolving Retail Landscape Consumer Sentiment Plunges to Record Low in May as Iran Conflict Drives Gas Prices Higher Sonida Senior Living SNDA Q1 2026 Earnings WiderThanExpected Loss Signals Persistent Operational Headwinds Leslies Inc Q1 2026 Earnings Significant EPS Miss Despite Strong Stock Rally MDRR Q2 2021 Earnings EPS Surprises to the Upside Despite Revenue Absence SERV Q1 2026 Earnings EPS Misses Estimates Amid Revenue Uncertainty TSSI Q1 2026 Earnings Massive EPS Beat Fails to Lift Stock as Revenue Remains Undisclosed Community West Bancshares CWBC Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction Micron Technology MU Gains 149 USA TODAY Co Inc TDAY Holds Steady at 756 as Traders Eye Key Support and Resistance Levels Freightos CRGO Slips 073 Testing Support Amid Freight Sector Headwinds Arrow Financial Corporation AROW Edges Lower Amid Broader Sector Weakness National Vision Holdings EYE Hovers Near Flat as Stock Tests Key Support Levels Latin American Leaders at WUF13 Call for New Housing Finance Models and ClimateResilient Urban Development WATT Q1 2026 Earnings NarrowerthanExpected Loss Reflects Effective Cost Control ASPCU Units Hold Steady at 140 Amid Quiet Trading Key Levels to Watch Neonode Inc NEON Q1 2026 Earnings EPS Misses Estimates by Nearly 8 NXE Q1 2026 Earnings WiderthanExpected Loss Amid Strategic Progress in Uranium Development AUR Q1 2026 Earnings Narrower Loss Surprises Market as Autonomous Truck Developer Progresses PDEX Q1 2026 Earnings EPS Surges 8975 Above Estimates Amid Stock Decline Seneca Foods Q1 2026 Earnings Strong EPS of 619 Despite Modest Stock Reaction TCRT Q4 2023 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports No Revenue PRME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress